137 related articles for article (PubMed ID: 23777696)
1. Perspectives on sustainable vaccine introduction.
Hinman AR
Vaccine; 2013 Jul; 31 Suppl 3():C8-9. PubMed ID: 23777696
[No Abstract] [Full Text] [Related]
2. Historical perspectives on new vaccine introduction in Latin America and the Caribbean.
de Quadros C
Vaccine; 2013 Jul; 31 Suppl 3():C4-5. PubMed ID: 23777690
[No Abstract] [Full Text] [Related]
3. Beyond methods and studies: building institutions for better public spending on vaccination.
Glassman A
Vaccine; 2013 Jul; 31 Suppl 3():C10-1. PubMed ID: 23777682
[No Abstract] [Full Text] [Related]
4. Evidence base for new vaccine introduction in Latin America and the Caribbean.
Andrus JK; Walker DG
Vaccine; 2013 Jul; 31 Suppl 3():C2-3. PubMed ID: 23777687
[No Abstract] [Full Text] [Related]
5. Evidence base for vaccine introduction in Latin America and the Caribbean. Foreword.
Etienne CF
Vaccine; 2013 Jul; 31 Suppl 3():C1. PubMed ID: 23777681
[No Abstract] [Full Text] [Related]
6. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.
Toscano CM; Jauregui B; Janusz CB; Sinha A; Clark AD; Sanderson C; Resch S; Ruiz Matus C; Andrus JK;
Vaccine; 2013 Jul; 31 Suppl 3():C12-8. PubMed ID: 23777685
[TBL] [Abstract][Full Text] [Related]
7. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
8. What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.
Whitney CG; Parashar UD
Vaccine; 2013 Jul; 31 Suppl 3():C6-7. PubMed ID: 23777693
[No Abstract] [Full Text] [Related]
9. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region.
de Oliveira LH; Toscano CM; Sanwogou NJ; Ruiz-Matus C; Tambini G; Roses-Periago M; Andrus JK
Vaccine; 2013 Jul; 31 Suppl 3():C114-22. PubMed ID: 23777684
[TBL] [Abstract][Full Text] [Related]
10. The structure and function of immunization advisory committees in Western Europe.
Freed GL
Hum Vaccin; 2008; 4(4):292-7. PubMed ID: 18398300
[TBL] [Abstract][Full Text] [Related]
11. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
[TBL] [Abstract][Full Text] [Related]
12. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
Al Awaidy S
Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
[TBL] [Abstract][Full Text] [Related]
13. Indicators to assess National Immunization Technical Advisory Groups (NITAGs).
Blau J; Sadr-Azodi N; Clementz M; Abeysinghe N; Cakmak N; Duclos P; Janusz C; Jauregui B; Mihigo R; Mosina L; Takashima Y; Senouci K
Vaccine; 2013 May; 31(23):2653-7. PubMed ID: 23398930
[TBL] [Abstract][Full Text] [Related]
14. The Caribbean Immunization Technical Advisory Group (CITAG); A unique NITAG.
Evans-Gilbert T; Lewis-Bell KN; Figueroa JP
Vaccine; 2019 Oct; 37(44):6584-6587. PubMed ID: 31537448
[TBL] [Abstract][Full Text] [Related]
15. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a National Immunization Technical Advisory Group in Côte d'Ivoire: process and lessons learned.
Blau J; Faye PC; Senouci K; Dagnan SN; Douba A; Saracino JT; Gessner BD
Vaccine; 2012 Mar; 30(15):2588-93. PubMed ID: 22330125
[TBL] [Abstract][Full Text] [Related]
17. Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups.
Chocarro L; Duclos P; Senouci K; Southern J
Expert Rev Vaccines; 2011 Sep; 10(9):1265-70. PubMed ID: 21919616
[TBL] [Abstract][Full Text] [Related]
18. Immunization policy development in Thailand: the role of the Advisory Committee on Immunization Practice.
Muangchana C; Thamapornpilas P; Karnkawinpong O
Vaccine; 2010 Apr; 28 Suppl 1():A104-9. PubMed ID: 20412989
[TBL] [Abstract][Full Text] [Related]
19. Immunization and Vaccine related Implementation Research Advisory Committee (IVIR-AC): summary of conclusions and recommendations 17–19 September 2014 meeting.
Wkly Epidemiol Rec; 2015 Jan; 90(1-2):1-8. PubMed ID: 25585441
[No Abstract] [Full Text] [Related]
20. Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system.
Hyde TB; Andrus JK; Dietz VJ; ; Andrus JK; Hyde TB; Lee CE; Widdowson MA; Verani JR; Friedman C; Azziz-Baumgartner E; Lopez AS; Jumaan A; Dietz VJ
Vaccine; 2013 Jul; 31 Suppl 3(0 3):C94-8. PubMed ID: 23777699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
